Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Costliest Medicare Markets In Florida, New York, California
U.S. News & World Report examines cost, frequency, and outcomes studies on Medicare patients from the Dartmouth Institute for Health Policy and Clinical Practice : "The Dartmouth research is particularly relevant to older Americans because it is based to a large extent on Medicare data, involving patients ages 65 and older. The 2008 atlas, in particular, paints a devastating portrait of Medicare treatments based on an extensive study of Medicare recipients who died from one or more of nine chronic illnesses. Not only are chronic illnesses very expensive to treat, but they"re also the cause of most deaths in the United States. According to the 2008 atlas: More than 90 million Americans live with at least one chronic illness, and 7 out of 10 Americans die from chronic disease. Among the population that receives Medicare, the toll is even greater: About 9 out of 10 deaths are associated with just nine chronic illnesses: congestive heart failure, chronic lung disease, cancer, coronary artery disease, renal failure, peripheral vascular disease, diabetes, chronic liver disease, and dementia."
generic viagra online
Report: Health Industry Spends Upwards Of $1.4 Million A Day On Lobbyists
"In a new report released yesterday, the government watchdog group Common Cause found that major health care interests have spent upwards of $1.4 million a day to lobby Capitol Hill so far this year," the National Journal reports. This political spending amount represents a 73 percent increase since 2000. In addition, the report finds that campaign contributions to members of Congress jumped $40 million since 2000, to $94 million in the 2008 election cycle (Krigman, 6/24).
News of the day
The Myth And Reality Of Gun Crime In The UK
The assumption that gangs are at the root of gun crime in the UK is overstated, according to a study published in a special issue of Criminology and Criminal Justice, published by SAGE.
Mental Health

Mantle Cell Lymphoma Consortium Scientific Workshop - Report From Sixth Annual Meeting Now Available

Almost 60 mantle cell lymphoma (MCL) specialists from around the world gathered in Atlanta, GA for the Lymphoma Research Foundation"s (LRF) Sixth Annual Mantle Cell Lymphoma Consortium (MCLC) Scientific Workshop. Attendees heard presentations addressing several key issues including the biology of MCL, prognostic indicators, new molecular targets, chemoimmunotherapy, transplantation and novel therapeutic approaches. The MCLC was established by the Lymphoma Research Foundation (LRF) in 2005 to accelerate the pace of mantle cell lymphoma research. Attendees to this year"s workshop included: LRF MCLC members, including LRF MCL grant recipients as well as other scientific investigators conducting cutting-edge research. As in the past, this year"s meeting provided a unique opportunity for experts to report on their research findings and exchange ideas on how to best improve treatment options for individuals living with MCL. Those in attendance heard 17 oral presentations, viewed 9 poster presentations and participated in 6 roundtable discussions covering areas such as: Clinical Trails for Younger Patients, Epigenetic Studies in MCL and Cell Cycle Targets for MCL. About Mantle Cell Lymphoma Mantle cell lymphoma (MCL) is a B-cell lymphoma that gets its name because mantle cell tumors are composed of cells that come from the "mantle" zone of the lymph node. Frequently, MCL is diagnosed as a stage 4 disease, often present in lymphnodes above and below the diaphragm and in most cases involves the gastrointestinal tract and bone marrow. MCL is a relatively rare disease, constituting only about 6 percent of all NHL cases in the United States (i.e., only about 3,000 cases per year in the U.S.). This lymphoma usually affects men over the age of 60. Lymphoma Research Foundation


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009